Association Between Alzheimer's Disease And Removal Of The Synaptic Protein ADAM10
In this issue of the Journal of Clinical Investigation, Monica Di Luca and colleagues at the University of Milan in Milan, Italy, report that ADAM10 is removed from synapses through association with the protein AP2. Strikingly, the association between ADAM10 and AP2 was increased in human brain homogenates from Alzheimer's disease (AD) patients compared to healthy controls. Neuronal activity was shown to influence the level and activity of ADAM10 in synapses and its association with AP2.
These studies identify pathological mechanisms associated with AD that control the localization of proteins at the synapse.
TITLE: Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease
View this article at: http://www.jci.org/articles/view/65401?key=ae8059e94294f112e5b2
Source: EurekAlert!, the online, global news service operated by AAAS, the science society
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Association Between Alzheimer's Disease And Removal Of The Synaptic Protein ADAM10." Medical News Today. MediLexicon, Intl., 10 May. 2013. Web.
23 May. 2017. <http://www.medicalnewstoday.com/releases/260308.php>
Journal of Clinical Investigation. (2013, May 10). "Association Between Alzheimer's Disease And Removal Of The Synaptic Protein ADAM10." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.